Overview

Efficacy of Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in Chronic Kidney Disease (CKD) Patients

Status:
Unknown status

Trial end date:
2010-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to demonstrate the efficacy of alpha tocopherol for prevention contrast-induced nephropathy in CKD patients undergoing elective coronary procedures.

Phase:

Phase 3

Details

Lead Sponsor:

Thammasat University

Treatments:

alpha-Tocopherol
Tocopherols
Tocotrienols
Vitamin E
Vitamins